et al.. Nauclea latifolia Smith (Rubiaceae) exerts antinociceptive effects in neuropathic pain induced by chronic constriction injury of the sciatic nerve.
Introduction
The pathophysiological mechanisms underlying neuropathic pain have been reviewed extensively in recent years, and the results reflect both peripheral and central sensitization mechanisms (Moalem and Tracey, 2006) . The International Association for the Study of Pain defines neuropathic pain as pain initiated or caused by a primary lesion or dysfunction in the nervous system (Merskey, 1991) . Clinically, the presence of neuropathic pain is often characterized by stimulus-independent persistent pain or abnormal sensory perception of pain, such as allodynia (a painful response to a normally innocuous stimulus) and hyperalgesia (exaggerated pain sensations as a result of exposure to a mildly noxious stimulus) (Ueda and Rashid, 2003) . Neuropathic pain is pain that arises from damage to the part of the nervous system that carries sensory information to the brain. It is difficult to treat because of its severity, duration and resistance to simple painkillers.
Examples of central neuropathic pain include post-stroke pain, affecting up to 8% of post-stroke patients, and neuropathic pain associated with multiple sclerosis in 50% of patients and with spinal cord injury in 40% of patients (Werhagen et al., 2007) . Peripheral neuropathic pain states include painful diabetic neuropathy affecting approximately 25% of people with diabetes, sciatica, post-surgical and post-traumatic neuralgias. Post herpetic neuralgia is an example of a mixed neuropathic pain, with both peripheral and central mechanisms, affecting a significant proportion of patients following shingles (Andersen et al., 1995; Davies et al., 2006; Hewitt et al., 1997; Jung et al., 2004; Kehlet et al., 2006; Osterberg et al., 2005; Siddall et al., 2003) . Most patients with neuropathic pain respond poorly to traditional analgesics and many require a multidisciplinary approach. With current available treatments, only 30-50% of patients with neuropathic pain experience meaningful improvement in pain and function, and a long-term commitment from the patient and physician are required to ensure compliance and appropriate outcomes (Bennett, 2007) .
In the north of Cameroon, the leaves of Nauclea latifolia Smith (Rubiaceae) is used in traditional medicine for the treatment of cerebral malaria, behavioural disturbances in mentally-retarded children or central nervous system diseases, such as anxiety, depression and epilepsy (Dalziel, 1937; Adjanohoun et al., 1996; Arbonnier, 2000) . The roots decoction of Nauclea latifolia is effective in cases of fever, headache, migraine, pain, inflammatory disorders and neuropathic pain (Biholong, 1986; Adjanohoun et al., 1996; Arbonnier, 2000; latifolia Abbah et al. (2009) and Taïwe et al. (2011) have demonstrated that oral administration of Nauclea latifolia extracts cause antipyretic, antinociceptive and antiinflammatory effects. Earlier chemical studies of Nauclea latifolia have indicated the presence of Naucleamides A-F, a new monoterpene indole alkaloids, strictosamide (Shigemori et al., 2002 , Ata et al., 2009 , flavonoids, saponins, tannins, anthraquinones and phenols in the Nauclea latifolia extracts (Ngo Bum et al., 2009; Taïwe et al., 2011) .
In the present study, in order to provide a pharmacological basis to the traditional use of Nauclea latifolia as antinociceptive therapy in neuropathic pain and to discover novel analgesic drugs from natural resources, we investigated the antiallodynic and antihyperalgesic effects of the alkaloid fraction from Nauclea latifolia roots on CCI of the sciatic nerve, a rat model of neuropathic pain, using the Von Frey and acetone tests.
Materials and methods

Plant material
The roots of Nauclea latifolia was harvested in March 2009 from the National Park of Benoué (North Cameroon) and identified in the National Herbarium, Yaoundé Cameroon by comparison to an existing voucher specimen No. 20144/SRF/Cam.
Solvent-guided fractionation of Nauclea latifolia and bioactivity guided studies
The dried and powdered roots of Nauclea latifolia (1000 g) were extracted with acetone/H 2 O (7:3; 5 l) at room temperature. The combined extracts were evaporated in vacuo to afford a dark residue (381.61 g). The residue was suspended in warm water (1 l) and then extracted successively with ethyl acetate (0.5 l × 3) and n-butanol (0.5 l × 3), and concentrated to give residue A (133.25 g) and B (371.14 g), respectively. The latter was resolved in warm water (1 l), acidified with HCl (1 N) to pH 4-5, and extracted with CHCl 3 (0.5 l × 3). The aqueous layer was neutralized with NaOH (1 N) to pH 9-10 and extracted with CHCl 3 (0.5 l × 3) once again and concentrated in vacuo to obtain the crude base (136.12 g; 36.67%). The crude base (136.12 g) was subjected to a chromatography column with silica gel and eluted with CHCl 3 /CH 3 OH/ 28% NH 4 OH (50:1:0.1 → 3:1:0.1) to afford thirteen fractions: Fr. I (12.51 g; 9.19%), Fr. II (6.34 g; 4.66%), Fr. III (17.68 g; 12.99%), Fr. IV (16.35 g; 12.01%), Fr. V (11.45 g; 8.41%), Fr. VI (92.42 mg; 0.07%), Fr. VII (75.43 mg; 0.05%), Fr. VIII (41.27 mg; 0.03%), Fr. IX (39.15 mg; 0.03%), Fr. X (4.21 g; 3.09%), Fr. XI (1.29 g; 0.95%), Fr. XII (56.94 mg; 0.04%), Fr. XII (513.54 mg; 0.38%). Bioactivity-guided studies on the extract and fractions using Von Frey test showed that the fraction IV from the roots of Nauclea latifolia significantly attenuated mechano-hyperalgesia of all CCI rats with 85.26 ± 9.17%, compared to the control group.
Sample preparation, chromatographic analysis and bioactivity guided studies
10 mg sample of the fractions IV was dissolved in 10 ml methanol. The solution was filtered through membrane filter (pore size 0.45 µm) prior to high-performance liquid chromatography analysis. The sample was analysed by means of a HPLC system (AKTA TM Purifier, Amersham Biosciences). The alkaloid fraction derived from Nauclea latifolia was analysed by HPLC using a Vydac C18 column (218TP1010, 25 × 10 cm, 10 µm), and for elution of the constituents, a gradient of two solvents denoted A and B was employed. The mobile phases were (A) 90% acetonitrile with water and (B) 0.1% trifluoroacetic acid with water. The flow rate used was 1.0 ml/min and the injection volume was 10 ml. The retention time and UV spectrum of major peaks were analyzed. The eluant was monitored at 215 nm.
The fractions eluted were combined, and then lyophilized [F 1 (0.03 mg; 0.30%), F 2 (0.1 mg; 10%), F 3 (0.13 mg; 1.30%); F 4 (0.07 mg; 0,70%), F 5 (0.11 mg; 1.10%), F 6 (0.04 mg; 0.40%), Further activity-guided studies on the sub-fractions (F 1 -F 8 ) showed that the powders yielded by F 3 exhibited the most potent antinociceptive effects by causing a dose-dependent inhibition of mechanical hyperalgesia in CCI rats using Von Frey test. The collected fraction F 3 was dissolved in vehicle (saline containing dimethyl sulfoxyde 2%) and screned for further activities.
4. Animals
Male Wistar rats (160-180 g), and male and female Swiss mice (25-30 g) were used. 
Production of neuropathy and behavioral testing
Surgery
The chronic constriction injury of the sciatic nerve model was employed according to methods described by Bennett and Xie (Bennett and Xie, 1988) . Under thiopental sodium anesthesia (Sigma chemical, St Louis, USA, 35 mg/kg; i.p.), the right common sciatic nerve was exposed by blunt dissection through the biceps femoris, at the level of mid-thigh.
Proximal to the sciatic trifurcation, the nerve was freed of adhering tissue, and four ligatures with 3-0 silk thread were tied loosely around the nerve with a spacing of about 1 mm, taking care not to interrupt the epineural circulation. After surgery, the muscle and skin were closed in two layers using absorbable chronic catgut 4-0 for the muscle and 3-0 silk thread for the skin. In sham-operated controls, an identical surgical procedure was performed, except that the sciatic nerve was not ligatured. All surgical procedures were performed under normal sterile conditions by the same person. After operation, the rats were allowed to recover for 1 week.
Von Frey test
To quantify mechanical sensitivity of the foot, a brisk foot withdrawal in response to normally innocuous mechanical stimuli was measured as described previously (Kim and Chung 1992) . Six rats were used for each treatment (n = 6 per group). The rats were placed in acrylic cages on top of a wire mesh grid that allowed their paws access to the Von Frey filaments. The rats were adapted to the testing situation, and they were allowed to habituate until exploratory behaviour diminished for at least 10 min before stimulation was initiated.
Bending forces of 1, 6, 10 and 15 g to the mid-plantar skin of each hind paw were then applied in increasing order from the weakest to the strongest. Beginning with the lowest force, the filament was placed on the skin until it bowed slightly, with each filament presented ten times at a rate of about 1/s. The paw-withdrawal threshold was defined as the percent force eliciting an active withdrawal on the affected ipsilateral paw. A response was recorded every 30 min for 180 min post-dosing if the rat withdrew its hind paw from the filament. The effects of acute administration of the alkaloid fraction from Nauclea latifolia (8, 16, 40 and 80 mg/kg; i.p.), morphine (Sigma chemical, St Louis, USA, 5.6 mg/kg; s.c.) or vehicle (10 ml/kg; saline containing dimethyl sulfoxyde 2%, i.p.) on mechanical sensitivity were tested between at day 12 post-surgery.
Acetone test
To quantify cold sensitivity of the foot, brisk foot withdrawal in response to acetone application was measured as described previously (Choi et al., 1994) . Six rats were used for each treatment (n = 6 per group). With the animals inside acrylic cages on the elevated grid, a drop of acetone was delicately applied to the plantar surface of the hind paw without touching the skin using a blunt plastic needle connected to a syringe. A response was recorded if the rat withdrew its hind paw in response to acetone application. The time spent with the leg withdrawn from the floor during the 60 s following exposure to acetone was recorded. Both hind legs were tested in each animal, beginning with the unoperated left leg, and each stimulus was applied three times at intervals of approximately 5 min. The duration of lifting of the hind paw after acetone stimuli was recorded with a stopwatch every 30 min for 180 min post-dosing (Dowdall et al., 2005) . The effects of acute administration of the alkaloid fraction from Nauclea latifolia (8, 16, 40 and 80 mg/kg; i.p.), morphine (5.6 mg/kg; s.c.) or vehicle (10 ml/kg; saline containing dimethyl sulfoxyde 2%, i.p.; adequate controls were performed with the corresponding vehicles in CCI and sham rats) on cold sensitivity were tested between day 12 and day 14 post-surgery.
Motor assessment and signs of catalepsy
The motor coordination test was performed to determine side effects of the Nauclea latifolia alkaloid fraction using the rotating rod method (Taïwe et al., 2011) . The bar rotated at a constant speed of 16 revolutions per min. A preliminary selection of mice was made on the day of experiment prior to administration of extract or morphine (t 0 b), excluding those that did not remain on the rota-rod bar for two consecutive periods for 45 sec each. Six mice were used for each treatment (n = 6 per group). The integrity of motor coordination was assessed on the basis of the number of falls from the rota-rod in 180 sec. Selected animals were tested immediately at 0 (t 0 a), 30, 60, 90, and 120 min after administrations of the alkaloid fraction from Nauclea latifolia (8, 16, 40 and 80 mg/kg, i.p.) , morphine (5.6 mg/kg, s.c.), or vehicle (10 ml/kg; saline containing dimethyl sulfoxyde 2%, i.p.).
Catalepsy was evaluated according to the standard bar hanging procedure by placing the naive mice with both forelegs over a horizontal bar, elevated 4.5 cm from the floor (Sanberg et al., 1988) . Catalepsy was considered finished when the forepaw touched the floor or when the mouse climbed the bar. Eight mice were used for each treatment (n = 8 per group). Measurement was performed 30 and 60 min after administration of the alkaloid fraction from Nauclea latifolia (8, 16, 40 and 80 mg/kg; i.p.), morphine (5.6 mg/kg; s.c.) or vehicle (10 ml/kg; saline containing dimethyl sulfoxyde 2%, i.p.; adequate controls were performed with the corresponding vehicles in CCI and sham rats). The time during which the mouse maintained the cataleptic position was recorded for up to 300 sec, with three attempts allowed to replace the animal over the glass bar.
Acute toxicity and cell viability essay
The acute toxicity test for the alkaloid fraction from Nauclea latifolia was carried out to evaluate any possible toxicity. Mice of either sex (5 per sex = 10 per group) were divided into control and test groups. The first group served as a normal control treated with vehicle (10 ml/kg; saline containing dimethyl sulfoxyde 2%, i.p.). The alkaloid fraction from Nauclea latifolia was administered intraperitonealy to different groups at the increasing doses of 160, 320, 640, 960, 1280, 1600 mg/kg. After injections of the alkaloid fraction from Nauclea latifolia, mice were allowed access to food and water ad libitum and all animals were observed for general behavioral and body weight changes, hazardous symptoms and mortality for a period of 14 days after treatment (Taïwe et al., 2011) . The median lethal dose (LD 50 ) was estimated according to the method described by Litchfield and Wilcoxon (1949) .
Confirmatory tests were carried out and the LD 50 was calculated from the graph of probit mortality against dose of the extract.
Chinese hamster ovary (CHO) cell line from American Type Culture collection (ATCC) were maintained at 37°C in 5% CO2 in F-12K nutrient medium (InVitrogen) supplemented with 10% (v/v) heat-inactivated fetal bovine serum (InVitrogen) and 10,000 units/ml streptomycine and penicillin (InVitrogen). Chinese cell ovary cell were seeded into 96 well micro plates at density of approximately 8 × 10 8 cells/well. After 2 days of culture, the cells were incubated for 24 hours at 37°C with various concentrations of the alkaloid fraction from Nauclea latifolia (0, 20, 40, 80, 160, 320, 640, 960, 1280 and 1600 µg/ml).
Control wells containing cell culture medium alone or with cells, both without Nauclea latifolia fraction addition, were included in each experiment. The cells were then incubated 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl-tetrazolium bromide (MTT; Sigma, St Louis, MO, USA) for 30 min. Conversion of MTT into purple colored MTT formazan by the living cells indicated the extent of cell viability. The crystals were dissolved with dimethyl sulfoxide and the optical density was measured at 540 nm using microplate reader (Biotek ELx-800, Mandel Scientific Inc.) for quantification of cell viability. All assays were run in triplicates. Results were plotted as percent of cytotoxicity and concentration-response curves were fitted using Graph Pad Prism in order to determine the 50% effective concentration (EC 50 ) (Poillot et al., 2010) .
Data analyses and statistics
Data are expressed as mean ± S.E.M. The cumulative anti-nociceptive effect during the entire observation period (180 min) was determined as the area under the curve (AUC) of the time course. The AUCs for each of the assayed drugs were calculated by the trapezoidal method (Rowland and Tozer, 1989) . The data were compared using a two-way analysis of variance (ANOVA) followed by Bonferroni's post-hoc tests. A significant statistical difference was determined by value of at least p<0.05. ED 50 values and 95% confidence intervals (95% CI) were determined at the time of the peak effect for each drug by semilogarithmic regression analysis or according to Litchfield and Wilcoxon (1949) .
Results
Effects of the alkaloid fraction from Nauclea latifolia on mechanical hyperalgesia
Ten days after surgery, CCI rats developed statistically significant increases in responses to 1, 6, 10 and 15 g von Frey filament stimulation. CCI rats showed 7.25 ± 1.14% and 17.29 ± 3.18% of response frequency to 1 g and 6 g von Frey filament stimuli, respectively, compared with the sham-operated group, which did not show any reaction. Thus, this effect was a mechano-allodynic response. However, the stimuli of 10 g or 15 g von Frey filaments produced mechano-hyperalgesic responses in rats on day ten post-surgery. For example, when a 10 g filament stimuli was used in the sham group, 5.12 ± 1.53% was the observed response, while in CCI rats the percentage of response was 65.81 ± 2.14%.
Similarly, the stimuli of 15 g Von Frey filaments produced mechano-hyperalgesic responses in rats on day twelve post-surgery. When a 15 g filament stimuli was used in the sham group, 86.87 ± 2.59% was the observed antihyperalgesia, while in CCI rats the percentage of response was 8.54 ± 1.83% [F(6, 38) = 92.51; p>0.06]. 90 min post-injection of 80 mg/kg of the alkaloid fraction from Nauclea latifolia, significantly attenuated mechano-hyperalgesia of all CCI rats with 76.97 ± 4.21% [F(6, 38) = 92.51; p<0.001], compared to the vehicule group (Figure 2A) . The attenuation was most marked 60 min after injection for 40 mg/kg, and 180 min for 80 mg/kg. The maximum value of the AUC obtained in the Von test in sham rats (anti-hyperalgesic effects) under these experimental conditions was 288.52 ± 14.29 area units (a.u.) . At 180 min, the AUC was 198.25 ± 15.17 a.u. in CCI animals administered with 80 mg/kg of the alkaloid fraction, indicating that mechano-hyperalgesia had been significantly reversed [F(6, 38) = 92.51; p<0.05] . The alkaloids fraction showed potent and dose-dependent inhibition of mechanical hyperalgesia with an ED 50 value (95% CI) of 35.94 (24.25 -51.39) mg/kg ( Figure 2B ).
Effects of alkaloids fraction from Nauclea latifolia on cold allodinia
The three hour time courses of the anti-allodynic effects of the alkaloid fraction from Nauclea latifolia and morphine after a single i.p. administration are shown as the antiallodynic effects. Pronounced cold allodynia in response to acetone stimulation of the ipsilateral hind paw was observed in the CCI group in the acetone test 12 days after surgery.
The alkaloid fraction from Nauclea latifolia at the dose of 80 mg/kg induced significant antiallodynia effects of all CCI rats with 89.38 ± 3.59% [F(6, 29) = 103.62; p<0.001] using the acetone test ( Figure 3A) . The most pronounced effect was observed 2 hours after administration of the alkaloid fraction at the dose of 80 mg/kg. The percentage baseline allodynia in CCI rats, injected with vehicle, remained the same throughout the observation period, whereas the sham operated group did not present any response to this cold stimulus during the entire 3 hrs period of observation. The maximum value of the AUC obtained in the acetone test (anti-allodynic effect) under these experimental conditions was 271.40 ± 12.51 a.u. An AUC of 10.34 ± 2.59 a.u. was observed in the CCI rats which did not show antiallodynic effects. The alkaloid fraction showed significant differences at 80 mg/kg (149.57 ± 18.54 a.u.) [F(6, 31) = 145.71; p<0.001] compared with the CCI control group without treatment. The alkaloid fraction showed efficient anti-allodynic effects in the CCI model, with an ED 50 value (95% CI) of 38.26 (22.31 -49.67 ) mg/kg ( Figure 3B ).
Effects of the alkaloid fraction from Nauclea latifolia on motor coordination
evaluated by the number of falls from the rotarod apparatus and compared to animals receiving the vehicle. This alkaloid fraction did not affected motor coordination at all doses tested [F(5, 72) = 103.52; P>0.07). However, a large effect on motor coordination (19.44 ± 0.91 falls) [F(5, 72) = 103.52; p<0.001] was observed 30 min post administration with morphine at the dose of 5.6 mg/kg, compared with vehicle ( Table 1) .
The alkaloid fraction from Nauclea latifolia administered intraperitonealy did not induce any cataleptic effect either at low doses or at the higher dose. As can be seen in Figure   4 (Figure 4) .
Acute toxicity and cell viability assay
The results indicated that the acute treatment by intraperitoneal route at doses up to 1600 mg/kg of the alkaloid fraction from Nauclea latifolia did not produce any sign of toxicity or death in mice during 24 hours of observation. After 14 days, treated mice did not present any visible toxic effect. Furthermore, no lesions or bleedings were observed in internal organs such as lungs, kidneys, liver, heart and stomach. Neither absolute body weight nor body weight gain was affected by Nauclea latifolia fraction administration at all doses throughout the study. Since no death or damage was observed throughout the experiments, the LD 50 could not be estimated.
The ability of the alkaloid fraction from Nauclea latifolia to induce cytotoxicity was further investigated by using CHO cells and a standard MTT bioassay ( Figure 5 ). As shown, incubation for 24 hrs of these cells lines with the Nauclea latifolia fraction, up to a concentration of 160 μg/ml, produces no cell toxicity. The toxicity values observed were not significantly different from baseline and lower than 9.7 ± 3.5% [F(8, 32) = 147.25; p>0.07].
However, incubation of CHO cells with a higher concentration (640 µg/ml) of the Nauclea latifolia fraction produced greater cell death (30.2 ± 3.8%) [F(8, 32) = 147.25; p<0.001]. The viability of CHO cells decreased in a concentration-dependent manner ( Figure 5 ) with increasing concentrations of extract (EC 50 = 772.35 ± 13.41 µg/kg) after 24h treatment.
Discussion
The present study investigated the anti-allodynic and antihyperalgesic effects of the alkaloid fraction from Nauclea latifolia on chronic constriction injury of the sciatic nerve as a model of neuropathic pain. This model is based on a unilateral loose ligation of the sciatic nerve, which is one of the most frequently used models for the study of neuropathic pain and its treatment. Chronic constriction injury in rats simulates the clinical condition of chronic nerve compression such as that occurring in nerve entrapment neuropathy or spinal root irritation by lumbar disk herniation. This model also shows many of the pathophysiological properties of chronic neuropathic pain in human subjects, such as allodynia and hyperalgesia (Bennett and Xie, 1988; De Vry et al., 2004) . In this study, 12 days after CCI, the rats showed a relatively high degree of similarity with other studies published on neuropathic pain in terms of the degrees of allodynia and hyperalgesia against cold and mechanical stimuli, demonstrated by the increased responsiveness to acetone stimulus and von Frey filaments (Bennett and Xie, 1988; De Vry et al., 2004; De la O-Arciniega et al., 2009 ).
The antinociceptive effects of the alkaloid fraction from Nauclea latifolia was well documented herein, as confirmed by the analysis of the AUC of anti-hyperalgesic effects over a time course of 3 hours post-dosing. Also, this alkaloid fraction induced a strong attenuation of cold allodynia, and the anti-allodynic effects persisted for 3 hours post-administration.
Similarly, morphine demonstrated antinociceptive effects on mechanical hyperalgesia and cold allodynia at the dose of 5.6 mg/kg. It is the most widely used opioid and the standard against which new agents are compared. This opioid drug has demonstrated antinociceptive efficacy in several models of nociception (López-Muñoz et al., 1993) , including neuropathic pain (De Vry et al., 2004) . Morphine mediates its actions by binding and activating receptors in the peripheral nervous system, as well as those found in inhibitory pain circuits that descend from the midbrain to the spinal cord dorsal horn via presynaptic and, to a lesser extent, postsynaptic μ-opioid receptors modulating nociceptive transmission (Nicholson, 2003) . Other studies suggest that Nauclea latifolia extracts remarkably decreased both the acute and delayed phases of formaline-induced pain in animals and also caused a significant reduction in both yeast-induced pyrexia and egg albumin-induced oedema in rats (Abbah et al., 2010; Taïwe et al., 2011) . The antinociceptive effects exhibited by Nauclea latifolia extract in the formalin test was reversed by the systemic administration of naloxone (a nonselective opioid receptor antagonist), N ω -L-nitro-arginine methyl ester (L-NAME, a NO synthase inhibitor) or glibenclamide (an ATP-sensitive K + channel inhibitor) (Taïwe et al., 2011) . In the course of pharmacological studies, anticonvulsant, anxiolytic and sedative properties of Nauclea latifolia roots decoction (Ngo Bum et al., 2009; Taïwe et al., 2010) have already been reported from our laboratory. Neuropathic pain and epilepsy share neuronal hyperexcitability as a common underlying mechanism. There are established antiepileptic drugs that target the generation of neuronal hyperexcitability, and some of these have been proven to be effective in the treatment of various forms of neuropathic pain (Sindrup and Jensen, 2000) .
The results obtained in our study suggest that inhibition of neuropathic pain by Nauclea latifolia is not related to the reduction of spontaneous locomotor activity of animals and it's not induced catalepsy. The catalepsy test has been used to predict tranquillizer activity as well as to evaluate motor effects of drugs, particularly those related to the extra-pyramidal system (Sanberg, et al., 1988) .
In the present study, we did not observe any mortality case up to the doses of 1600 mg/kg of the alkaloid fraction from Nauclea latifolia. Therefore, we may suggest that the extract has no lethal toxicity in mice. As seen, using the more sensitive MTT assay, no cytoxicity has been observed on CHO cells lines incubated with alkaloids fraction from Nauclea latifolia at 160 μg/ml. MTT assay measured the metabolism of 3-(4,5dimethylthiazol-2-yl)2,5-diphenyl tetrazolium bromide to form formazan precipitate by mitochondrial dehydrogenase which only present in viable cells. Formazan accumulation directly reflected mitochondrial activity, which was an indirect measure of cell viability (Mosmann, 1983) .
In summary, a novel antinociceptive action of the alkaloid fraction from Nauclea latifolia has been confirmed against neuropathic pain induced by CCI of the sciatic nerve, a rat model of neuropathic pain, using the Von Frey and acetone tests, and showing no increase in side effects on motor coordination. Moreover, the anti-hyperalgesic and anti-allodynic action demonstrated in the present study supports, at least in part, the ethnomedical uses of this plant. 
